Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03226639
Other study ID # 69HCL17_0508
Secondary ID
Status Recruiting
Phase N/A
First received July 20, 2017
Last updated July 20, 2017
Start date November 2016
Est. completion date May 2018

Study information

Verified date July 2017
Source Hospices Civils de Lyon
Contact Pierre LANTELME
Phone +33 4 72 07 16 67
Email pierre.lantelme@chu-lyon.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The ablation of atrial fibrillation (FA) by disconnection of pulmonary veins is a burgeoning intervention. It allows a long-term treatment of this arrhythmia with a success rate of about 80%. There are, nevertheless, some recidivism.

Risk factors for recidivism are poorly codified and need further research. Indeed the identification of factors of poor prognosis could lead to not propose this procedure to the patients who present them and at least to inform them of an increased risk of failure.

To date, aortic stiffness has not been studied in the context of assessing the risk factors for FA recurrence after ablation. On a physiopathological level, the aortic stiffness leads to increase left ventricle's post-load. Cardiac remodeling was observed with diastolic dysfunction and increased left atrial size. That may constitute a substrate for FA recurrence.

In the literature, aortic stiffness can be measured in several ways:

1. Measurement of systolo-diastolic variation of the inner diameter of the aorta by scanner or transesophageal Echography (ETO).

2. Measuring of the Pulse Wave Velocity.

3. Measurement of aortic calcifications.

The investigators propose to evaluate the impact of aortic stiffness on the recidivism of FA 6 months after ablation procedure performed in the Croix-Rousse cardiology's department.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date May 2018
Est. primary completion date May 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria :

- 18 years old of both sexes,

- Patient carrying a paroxysmal or persistent atrial fibrillation, benefiting from a first procedure of atrial fibrillation's ablation in the in the Croix-Rousse cardiology's department.

- Patient who signed the consent to participate in the study.

Exclusion Criteria :

- Patient carrying a permanent atrial fibrillation

- Patient who're in atrial fibrillation during the ablation

- Atrial fibrillation relapse's history after ablation

- Pregnant and nursing women

- Patients refusal.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
France Hospices Civils de Lyon - Hôpital de la Croix Rousse Lyon

Sponsors (1)

Lead Sponsor Collaborator
Hospices Civils de Lyon

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Atrial fibrillation recurrences Atrial fibrillation recurrences after 6 months of ablation by Holter ECG Month 6